mannheim

Did you know that Parkinson’s disease is the fastest-growing brain disease? At the same time, Parkinson’s disease is so variable, almost no 2 individuals’ symptoms and progression are the same. That is why at mediri, we are working every day to improve the diagnosis and therapy of Parkinson’s disease using advanced MR Imaging and Focused Ultrasound techniques.

For more details, you can have a look at this publication on automatic planning of MR-guided transcranial focused ultrasound treatment or this review article on blood-brain barrier dysfunction imaging.

Recently, a newspaper article about our project with bosomshield got mentioned in the newspaper echo-online. If you want to know more about the importance of our work and how we want to improve the field of breast cancer, you can read the article down below. 

a newspaper article scan

Today is International Day of Radiology to promote the seismic impact of radiology on medicine – earlier detection, fewer surgeries, and game-changing treatment outcomes. Analyzing radiological images in multi centric clinical studies can be challenging considering standardization and patient data privacy.
Mediri is constantly evolving its image data management platform mTRIAL for secure and reliable central reads in clinical studies. Currently, mTRIAL is getting ready for RANO 2.0 evaluation of low- and high-grade gliomas according to the recently published update by Wen et al. Stay posted.

RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults | Journal of Clinical Oncology (ascopubs.org)

New office. New Neighbours. New view.
It’s done! We have offically moved to Am Taubenfeld 21/1 in 69123 Heidelberg.

These numbers again stress the importance of research in breast cancer detection and relapse prediction. We are proud to be part of the Marie-Sklodowska Curie network bosomshield.eu aiming at the combination of clinical, pathological and radiological data for better treatment and therapies. Still, early detection of breast cancer is one of the most important factors for successfull treatment, so be mindful and take care of yourself!

World Alzheimer’s Day is a global effort to raise awareness and challenge the stigma around Alzheimer’s disease and other dementia. Do you know the differences between Alzheimer’s and dementia?
Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Alzheimer’s is one of several potential reasons for this decline, among them Frontotemporal Dementia, Huntington’s Disease, Parkinsons’s, or Vascular Dementia. Functional brain imaging is a cornerstone for the differentiation between all these different types of dementia and can support patient management as well as the research for potential therapies.
Perfusion imaging with Arterial Spin Labeling MRI has the potential to differentiate between Alzheimer’s and FTD but lacks standardization. In the ASPIRE project we develop an easy-to-use ASL evaluation tool that helps physicians to compare the brain perfusion pattern of a patient to a healthy control group. For more information visit aspire-mri.eu and alz.org.

Thank you for attending our ASL-Dinner in Toronto, each and every one of you made it a great evening. In case you missed the presentation video, find it below. We are proud and happy to be an integral part of the #ismrm. The annual meeting offered again an interesting exchange on the latest trends in MR imaging.

Have you read one of the latest publications on iron rim lesions in multiple sclerosis by our research partners at the Universitätsmedizin Mannheim? The authors around Prof. Achim Gass conclude that iron rim lesions are associated with higher intrathecal immunoglobin G synthesis. Furthermore, CSF-mediated intrathecal smouldering inflammation could explain a CSF-related gradient of tissue damage.
Read the publication here.

Thank you for having us at the BosomShield kick off meeting. BosomShield is a project aiming a computer-aided design system for breast cancer classification and prognosis of relapse.
If you want to know further information about this project, visit bosomshield.eu.

Have you ever thought about assessing cerebral perfusion non-invasively in your next clinical trial? If so, this recently published review paper will address the most important questions such as how to equalize data acquisition across sites, how to perform QC and process the data. 
Read more here: https://lnkd.in/gE3Z8BKT